Related references
Note: Only part of the references are listed.PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension
Jan K. Hennigs et al.
CIRCULATION RESEARCH (2021)
Bola3 Regulates Beige Adipocyte Thermogenesis via Maintaining Mitochondrial Homeostasis and Lipolysis
Ningning Bai et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
PPARγ Mediates the Anti-Epithelial-Mesenchymal Transition Effects of FGF1ΔHBS in Chronic Kidney Diseases via Inhibition of TGF-β1/SMAD3 Signaling
Dezhong Wang et al.
FRONTIERS IN PHARMACOLOGY (2021)
PPARγ is a gatekeeper for extracellular matrix and vascular cell homeostasis: beneficial role in pulmonary hypertension and renal/cardiac/pulmonary fibrosis
Gabor Kokeny et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2020)
TGF-β1 attenuates mitochondrial bioenergetics in pulmonary arterial endothelial cells via the disruption of carnitine homeostasis
Xutong Sun et al.
REDOX BIOLOGY (2020)
Treatment with a PPAR-γ Agonist Protects Against Hyperuricemic Nephropathy in a Rat Model
Xin Wang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2020)
Transcriptome analysis reveals a protective role of liver X receptor alpha against silica particle-induced experimental silicosis
Wu Yao et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2020)
SCUBE1 Controls BMPR2-Relevant Pulmonary Endothelial Function Implications for Diagnostic Marker Development in Pulmonary Arterial Hypertension
Wei Sun et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2020)
Tribbles Homolog 3-Mediated Vascular Insulin Resistance Contributes to Hypoxic Pulmonary Hypertension in Intermittent Hypoxia Rat Model
Fang Fan et al.
FRONTIERS IN PHYSIOLOGY (2020)
BOLA (BolA Family Member 3) Deficiency Controls Endothelial Metabolism and Glycine Homeostasis in Pulmonary Hypertension
Qiujun Yu et al.
CIRCULATION (2019)
Protective effect of rosiglitazone on chronic renal allograft dysfunction in rats
Jin Deng et al.
TRANSPLANT IMMUNOLOGY (2019)
Pioglitazone Therapy in Patients With Stroke and Prediabetes A Post Hoc Analysis of the IRIS Randomized Clinical Trial
J. David Spence et al.
JAMA NEUROLOGY (2019)
Fibroblast mTOR/PPARγ/HGF axis protects against tubular cell death and acute kidney injury
Yuan Gui et al.
CELL DEATH AND DIFFERENTIATION (2019)
LRP1 Deficiency in Vascular SMC Leads to Pulmonary Arterial Hypertension That Is Reversed by PPARγ Activation
Laurent Calvier et al.
CIRCULATION RESEARCH (2019)
Chronic TGF-β1 Signaling in Pulmonary Arterial Hypertension Induces Sustained Canonical Smad3 Pathways in Vascular Smooth Muscle Cells
Laurent Calvier et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2019)
The PPARγ agonist pioglitazone prevents TGF-β induced renal fibrosis by repressing EGR-1 and STAT3
Agnes Nemeth et al.
BMC NEPHROLOGY (2019)
Pioglitazone downregulates Twist-1 expression in the kidney and protects renal function of Zucker diabetic fatty rats
Zijian Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Pioglitazone protects tubular cells against hypoxia/reoxygenation injury through enhancing autophagy via AMPK-mTOR signaling pathway
Xiaoqing Xi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Rosiglitazone Suppresses Calcium Oxalate Crystal Binding and Oxalate-Induced Oxidative Stress in Renal Epithelial Cells by Promoting PPAR-γ Activation and Subsequent Regulation of TGF-β1 and HGF Expression
Ya-Dong Liu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Uncoupling protein 1 inhibits mitochondrial reactive oxygen species generation and alleviates acute kidney injury
Ping Jia et al.
EBIOMEDICINE (2019)
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives
Marc Humbert et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Pulmonary arterial remodelling by deficiency of peroxisome proliferator-activated receptor- in murine vascular smooth muscle cells occurs independently of obesity-related pulmonary hypertension
Evren Caglayan et al.
RESPIRATORY RESEARCH (2019)
Human PAH is characterized by a pattern of lipid-related insulin resistance
Anna R. Hemnes et al.
JCI INSIGHT (2019)
Pioglitazone decreased renal calcium oxalate crystal formation by suppressing M1 macrophage polarization via the PPAR-γ-miR-23 axis
Zhiqiang Chen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2019)
Mitochondrial HSP90 Accumulation Promotes Vascular Remodeling in Pulmonary Arterial Hypertension
Olivier Boucherat et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
PPARγ Regulates Mitochondrial Structure and Function and Human Pulmonary Artery Smooth Muscle Cell Proliferation
Samantha M. Yeligar et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2018)
Pioglitazone attenuates aging-related disorders in aged apolipoprotein E deficient mice
Dan Shen et al.
EXPERIMENTAL GERONTOLOGY (2018)
Reversing the curse on PPARγ
Mitchell A. Lazar
JOURNAL OF CLINICAL INVESTIGATION (2018)
Pharmacological induction of hypoxia-inducible transcription factor ARNT attenuates chronic kidney failure
Bjoern Tampe et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
High phosphate-induced downregulation of PPARγ contributes to CKD-associated vascular calcification
Liang Liu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2018)
PPARγ agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation
Ekaterina Legchenko et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Impact of Altered Mineral Metabolism on Pathological Cardiac Remodeling in Elevated Fibroblast Growth Factor 23
Maren Leifheit-Nestler et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Mitochondrial metabolism in pulmonary hypertension: beyond mountains there are mountains
Miranda K. Culley et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Klotho and PPAR Gamma Activation Mediate the Renoprotective Effect of Losartan in the 5/6 Nephrectomy Model
Edgar Maquigussa et al.
FRONTIERS IN PHYSIOLOGY (2018)
PPARγ maintains the metabolic heterogeneity and homeostasis of renal tubules
Zhongshi Lyu et al.
EBIOMEDICINE (2018)
Sildenafil Prevents Podocyte Injury via PPAR-γ-Mediated TRPC6 Inhibition
Ramon Sonneveld et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Activation of peroxisome proliferator-activated receptor γ inhibits vascular calcification by upregulating Klotho
Lijuan Cheng et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Distinct but complementary contributions of PPAR isotypes to energy homeostasis
Vanessa Dubois et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Nephropathy in Pparg-null mice highlights PPARγ systemic activities in metabolism and in the immune system
Barbara Toffoli et al.
PLOS ONE (2017)
Rosiglitazone Inhibits Angiotensin II-Induced Proliferation of Glomerular Mesangial Cells via the G alpha q/Plc beta 4/TRPC Signaling Pathway
Linting Wei et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Immune regulation of systemic hypertension, pulmonary arterial hypertension, and preeclampsia: shared disease mechanisms and translational opportunities
Salema Jafri et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2017)
Transforming Growth Factor β1-and Bone Morphogenetic Protein 2/PPARγ-regulated MicroRNAs in Pulmonary Arterial Hypertension
Laurent Calvier et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Peroxisome proliferator-activated receptor-γ enhances human pulmonary artery smooth muscle cell apoptosis through microRNA-21 and programmed cell death 4
David E. Green et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2017)
Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus
Lawrence H. Young et al.
CIRCULATION (2017)
PPARγ Links BMP2 and TGFβ1 Pathways in Vascular Smooth Muscle Cells, Regulating Cell Proliferation and Glucose Metabolism
Laurent Calvier et al.
CELL METABOLISM (2017)
The Effect of Autophagy on Inflammation Cytokines in Renal Ischemia/Reperfusion Injury
Haibin Ling et al.
INFLAMMATION (2016)
Nuclear Factor Erythroid 2-Related Factor 2 Drives Podocyte-Specific Expression of Peroxisome Proliferator-Activated Receptor γ Essential for Resistance to Crescentic GN
Carole Henique et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial Hypertension
Evan L. Brittain et al.
CIRCULATION (2016)
Skeletal Muscle TRIB3 Mediates Glucose Toxicity in Diabetes and High-Fat Diet-Induced Insulin Resistance
Wei Zhang et al.
DIABETES (2016)
Activation of PPAR-γ inhibits PDGF-induced proliferation of mouse renal fibroblasts
Jiamei Lu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension
Thomas Bertero et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Effects of combination PPARγ agonist and angiotensin receptor blocker on glomerulosclerosis
Keizo Matsushita et al.
LABORATORY INVESTIGATION (2016)
Pioglitazone ameliorates renal ischemia reperfusion injury through NMDA receptor antagonism in rats
Amrit Pal Singh et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2016)
Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
W. N. Kernan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
MicroRNA-27a promotes renal tubulointerstitial fibrosis via suppressing PPARγ pathway in diabetic nephropathy
Xiaoyan Hou et al.
ONCOTARGET (2016)
Inhibition of heat shock protein 90 improves pulmonary arteriole remodeling in pulmonary arterial hypertension
Guo-Kun Wang et al.
ONCOTARGET (2016)
Renal tubular epithelium-targeted peroxisome proliferator-activated receptor-γ maintains the epithelial phenotype and antagonizes renal fibrogenesis
Min Zhao et al.
ONCOTARGET (2016)
Pioglitazone Enhances the Beneficial Effects of Glucocorticoids in Experimental Nephrotic Syndrome
S. Agrawal et al.
SCIENTIFIC REPORTS (2016)
MicroRNA-27a Induces Mesangial Cell Injury by Targeting of PPARγ, and its In Vivo Knockdown Prevents Progression of Diabetic Nephropathy
Lina Wu et al.
SCIENTIFIC REPORTS (2016)
MicroRNA-27b plays a role in pulmonary arterial hypertension by modulating peroxisome proliferator-activated receptor γ dependent Hsp90-eNOS signaling and nitric oxide production
Rui Bi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Genetic Variation Determines PPARγ Function and Anti-diabetic Drug Response In Vivo
Raymond E. Soccio et al.
CELL (2015)
Matrix Remodeling Promotes Pulmonary Hypertension through Feedback Mechanoactivation of the YAP/TAZ-miR-130/301 Circuit
Thomas Bertero et al.
CELL REPORTS (2015)
The MicroRNA-130/301 Family Controls Vasoconstriction in Pulmonary Hypertension
Thomas Bertero et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Skeletal muscle proteomic signature and metabolic impairment in pulmonary hypertension
Simon Malenfant et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2015)
Renal Lipotoxicity-Associated Inflammation and Insulin Resistance Affects Actin Cytoskeleton Organization in Podocytes
Cristina Martinez-Garcia et al.
PLOS ONE (2015)
Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension
Thomas Bertero et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Hsp90 modulates PPARγ activity in a mouse model of nonalcoholic fatty liver disease
Matthew C. Wheeler et al.
JOURNAL OF LIPID RESEARCH (2014)
Early chronic kidney disease-mineral bone disorder stimulates vascular calcification
Yifu Fang et al.
KIDNEY INTERNATIONAL (2014)
Triglycerides in the Human Kidney Cortex: Relationship with Body Size
Ion Alexandru Bobulescu et al.
PLOS ONE (2014)
Hsp90 chaperones PPARγ and regulates differentiation and survival of 3T3-L1 adipocytes
M. T. Nguyen et al.
CELL DEATH AND DIFFERENTIATION (2013)
A randomized placebo controlled double blind crossover study of pioglitazone on left ventricular diastolic function in type 2 diabetes
Alun David Hughes et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
FK506 activates BMPR2 rescues endothelial dysfunction, and reverses pulmonary hypertension
Edda Spiekerkoetter et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Molecular fingerprinting of the podocyte reveals novel gene and protein regulatory networks
Melanie Boerries et al.
KIDNEY INTERNATIONAL (2013)
PPARγ signaling and metabolism: the good, the bad and the future
Maryam Ahmadian et al.
NATURE MEDICINE (2013)
Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model
Cristina Martinez-Garcia et al.
DISEASE MODELS & MECHANISMS (2012)
Effect of Thiazolidinedione Treatment on Proteinuria and Renal Hemodynamic in Type 2 Diabetic Patients with Overt Nephropathy
F. Pistrosch et al.
HORMONE AND METABOLIC RESEARCH (2012)
Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis
Hikaru Sugimoto et al.
NATURE MEDICINE (2012)
Protective effects of PPAR gamma agonist in acute nephrotic syndrome
Yiqin Zuo et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs
Marion Peyrou et al.
PPAR RESEARCH (2012)
Mitochondrial Dysfunction Mediates Aldosterone-Induced Podocyte Damage A Therapeutic Target of PPARγ
Chunhua Zhu et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Autoimmune Kidney Disease and Impaired Engulfment of Apoptotic Cells in Mice with Macrophage Peroxisome Proliferator-Activated Receptor gamma or Retinoid X Receptor alpha Deficiency
Tamas Roszer et al.
JOURNAL OF IMMUNOLOGY (2011)
Effect of Thiazolidinediones on Albuminuria and Proteinuria in Diabetes: A Meta-analysis
Pantelis A. Sarafidis et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Peroxisome Proliferator-Activated Receptor (PPAR)γ Can Inhibit Chronic Renal Allograft Damage
Eva Kiss et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Effects of PPAR gamma on hypertension, atherosclerosis, and chronic kidney disease
Akira Sugawara et al.
ENDOCRINE JOURNAL (2010)
Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells
Yu Jin Lee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Stretch reduces nephrin expression via an angiotensin II-AT1-dependent mechanism in human podocytes: effect of rosiglitazone
Ilaria Miceli et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Insulin resistance in pulmonary arterial hypertension
R. T. Zamanian et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
The PPARγ Agonist Pioglitazone Ameliorates Aging-Related Progressive Renal Injury
Hai-Chun Yang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta
Toru Kawai et al.
LABORATORY INVESTIGATION (2009)
PPARγ Activation: A Potential Treatment for Pulmonary Hypertension
Georg Hansmann et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
An antiproliferative BMP-2/PPARγ/apoE axis in human and murine SMCs and its role in pulmonary hypertension
Georg Hansmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
BMP-7 protects mesangial cells from injury by polymeric IgA
Wai Long Chan et al.
KIDNEY INTERNATIONAL (2008)
PPAR gamma in Kidney Physiology and Pathophysiology
Eva Kiss-Toth et al.
PPAR RESEARCH (2008)
PPAR-γ agonist protects podocytes from injury
T. Kanjanabuch et al.
KIDNEY INTERNATIONAL (2007)
Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-γ activation
Georg Hansmann et al.
CIRCULATION (2007)
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
Thomas A. Wynn
JOURNAL OF CLINICAL INVESTIGATION (2007)
Protection of the kidney by thiazolidinediones: An assessment from bench to bedside
P. A. Sarafidis et al.
KIDNEY INTERNATIONAL (2006)
TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism
Ling Qi et al.
SCIENCE (2006)
Chronic allograft nephropathy:: expression and localization of PAI-1 and PPAR-γ
MP Revelo et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Pioglitazone improves left ventricular diastolic function in patients with essential hypertension
T Horio et al.
AMERICAN JOURNAL OF HYPERTENSION (2005)
BMP-7 counteracts TGF-β1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury
M Zeisberg et al.
NATURE MEDICINE (2003)
TRB3:: A tribbles homolog that inhibits Akt/PKB activation by insulin in liver
KY Du et al.
SCIENCE (2003)
Peroxisome proliferator-activated receptor gamma (PPARγ) expression is decreased in pulmonary hypertension and affects endothelial cell growth
S Ameshima et al.
CIRCULATION RESEARCH (2003)
RAS point mutations and PAX8-PPARγ rearrangement in thyroid tumors:: Evidence for distinct molecular pathways in thyroid follicular carcinoma
MN Nikiforova et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor
C Atkinson et al.
CIRCULATION (2002)
Peroxisome proliferator-activated receptor-γ agonist troglitazone protects against nondiabetic glomerulosclerosis in rats
LJ Ma et al.
KIDNEY INTERNATIONAL (2001)
Gene expression patterns in the lungs of patients with primary pulmonary hypertension - A gene microarray analysis
MW Geraci et al.
CIRCULATION RESEARCH (2001)
Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction
KA Hruska et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2000)
Share Paper
